Owens & Minor Q1 adj EPS $0.19 (4x YoY); revenue $2.61B up 4%

ACCENDRA HEALTH INC/VA/

2024-Q1 EPS reported -$0.29 revenue$2,612,680,000

Adj EPS $0.19 vs $0.05 YoY; GAAP net loss per share $(0.29) vs $(0.32).
Revenue $2.61B, up 4% YoY; adjusted operating income $57.4M vs $47.7M.
Gross margin expanded 79 bps; adjusted operating margin up 31 bps.
Products & Healthcare Services segment grew, invested in inventory for new customers.
Patient Direct segment delivered mid-single digit top-line growth.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ACCENDRA HEALTH INC/VA/ reported the first quarter ended March 31, 2024 results: revenue $2.6 billion, net income $(0.29) per share.

Period: the first quarter ended March 31, 2024
Revenue: $2.6 billion
Net income: $(0.29) per share
Result: reported results

Exact text from the filing

VA – May 3, 2024 – Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2024. Key Highlights: ● Consolidated revenue of $2.6 billion in the first quarter, representing year-over-year growth of 4% ● GAAP operating margin was flat while adjusted operating margin expanded by 31 basis points versus prior year ●

View on SEC.gov

710 earnings releases filed in the last 30 days. Browse all earnings releases →

ACCENDRA HEALTH INC/VA/ filing history →

Source: SEC EDGAR

accession 0001558370-24-006589

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.